Molecular Subtypes of Endometrial Cancer and Their Therapeutic Implications: A Review Background

A Comprehensive Clinicopathological Analysis of Carcinoma of Endometrium: Histotype- Immunophenotype Correlation

OCT4, Ki-67 and VEGF as Prognostic Factors in Endometrial Carcinoma and Their Role in The Differentiation between Atypical Endometrial Hyperplasia and Grade 1 Endometrial Carcinom

Study of HER 2 expression in patients with Barrett’s esophagus and esophageal adenocarcinoma

P53 EXPRESSION AS A RISK FACTOR IN TYPE 1 ENDOMETRIAL CANCER

The prognostic significance of Minichromosome maintenance protein 2 (MCM2) and Trans-glutaminase 2 (TGM2) in Endometrial carcinoma: immunohistochemical and serological study

INTERNATIONAL ENDOMETRIAL TUMOR ANALYSIS AND ITS RELATION TO ENDOMETRIAL PATHOLOGY

Expression of Her-2/neu in endometrial carcinoma and its relation with clinicopathological variables

Expression of Bc-l2 in precancerous endometrial lesion and endometrial carcinoma

Prognostic Significance of L1CAM Expression in Endometrial Carcinoma